How Do You Die from Skin Cancer? Causes Explained

Skin cancer kills by spreading from the skin to vital organs, where growing tumors eventually disrupt the body’s ability to function. Melanoma is responsible for most skin cancer deaths, with an estimated 8,510 people dying from it in the U.S. in 2026 alone. The five-year survival rate for stage IV melanoma is just 16.2%. But the path from a skin lesion to a life-threatening illness involves several specific steps, and understanding them helps explain why early detection matters so much.

How Skin Cancer Spreads Beyond the Skin

A skin cancer that stays in one place is almost always curable with surgery. The danger begins when cancer cells break away from the original tumor and enter the bloodstream or lymphatic system, traveling to distant organs. This process, called metastasis, is what transforms a treatable skin problem into a fatal disease.

Traveling through the bloodstream is actually harsh on cancer cells. They face high levels of oxidative stress, a kind of chemical damage that destroys most of them before they can settle anywhere new. Research from the National Cancer Institute has shown that melanoma cells are more likely to survive this journey if they produce high levels of a protein that helps them absorb lactate from the blood. Lactate fuels their internal antioxidant defenses, essentially giving them armor against the hostile conditions of the circulatory system. The cells that survive then lodge in distant organs, where they begin forming new tumors.

Melanoma most commonly spreads to the lungs, liver, brain, bones, and lymph nodes. Once tumors establish themselves in these locations, they begin interfering with organ function in ways that can become fatal.

The Organs Most Often Affected

A study of 174 advanced melanoma deaths found that the most common causes were general body decline (57.5%), respiratory failure (22.4%), and infection (21.8%). Several other mechanisms contributed, including shock (16.7%), bleeding (9.8%), kidney failure (9.2%), and liver dysfunction (8.6%). Many patients experienced more than one of these problems simultaneously.

When melanoma spreads to the lungs or the tissue surrounding them, it can block airways or fill the space around the lungs with fluid, making it progressively harder to breathe. Patients with tumors in the lining of the lungs were more than twice as likely to die of respiratory failure. Liver metastases disrupt the organ’s ability to filter toxins, produce proteins the blood needs to clot, and regulate metabolism. As liver function declines, toxins build up, bleeding becomes harder to control, and the body’s chemistry destabilizes.

Brain Metastases and Neurological Decline

The brain is one of melanoma’s most dangerous destinations. Brain metastases are common in advanced melanoma and contribute to death in more than 50% of patients. Without treatment, patients with brain metastases typically survive less than three months.

Tumors in the brain cause damage in several ways. They take up physical space inside the skull, creating pressure that compresses healthy brain tissue. This pressure can cause seizures, severe headaches, confusion, personality changes, and loss of motor function. As tumors grow, they can also cause swelling and bleeding inside the brain. Eventually, critical brain structures responsible for breathing, heart rate, and consciousness become compromised. About 54% of patients with melanoma brain metastases die directly from the progression of those brain tumors rather than from disease elsewhere in the body.

How Nonmelanoma Skin Cancers Can Be Fatal

Melanoma gets the most attention, but squamous cell carcinoma and basal cell carcinoma can also kill. Squamous cell carcinoma has a case-fatality rate of only about 1%, but because it is so common, the total number of deaths rivals melanoma’s. Tumors larger than 4 centimeters and those that invade deeply into surrounding tissues or along nerves carry the highest risk. When squamous cell carcinoma does spread to lymph nodes, the three-year survival rate drops to roughly 69%.

Basal cell carcinoma rarely metastasizes, but it can kill through local destruction. These tumors grow slowly and relentlessly, and when neglected for years, they can invade into bone, particularly in high-risk areas of the face and skull. A review of 101 cases of basal cell carcinoma with bone invasion found an 18.2% risk of cancer-related death within five years. These are typically large, long-neglected tumors that erode into critical structures, sometimes reaching the brain or major blood vessels.

Why Treatment Sometimes Stops Working

Modern immunotherapy has dramatically improved outcomes for advanced melanoma, but a significant number of patients either don’t respond initially or stop responding over time. Cancer cells can develop ways to hide from the immune system, essentially learning to avoid the very defenses that immunotherapy activates. This resistance is often driven by multiple factors at once: the tumor itself changes to become less visible to immune cells, the surrounding tissue shifts into an immune-suppressed state, and broader factors in the body’s overall condition can reduce the effectiveness of treatment.

When treatment stops controlling tumor growth, the disease resumes its spread through the body. New metastases form, existing ones grow, and organ function progressively deteriorates.

What the Final Stage Looks Like

In the last weeks and days, the most common experience is a general decline that clinicians call “failure to thrive.” The body, overwhelmed by the burden of widespread disease, gradually loses its ability to maintain basic functions. People become profoundly fatigued and spend more time sleeping. They lose interest in food and water. Pain, shortness of breath, and confusion are common.

In the final days, physical changes become more pronounced. Breathing may become irregular, with periods of shallow breaths or brief pauses. Hands and feet can turn cool and blotchy as circulation slows. Heart rate and blood pressure become unstable. Many people become less responsive, answering questions slowly or not at all, and may seem unaware of their surroundings. A rattling sound during breathing, caused by fluid collecting in the throat when someone is too weak to clear it, is a sign that death is very near.

Some patients experience involuntary muscle twitches or jerks. Heavy bleeding can occur in the final hours, though this is rare. The immediate cause of death is most often respiratory failure, the heart stopping as blood pressure drops beyond recovery, or the brain losing its ability to regulate vital functions due to the cumulative burden of widespread disease.